A Study to Compare Two Tablet Forms of Tafamidis in Healthy Participants
Status:
Not yet recruiting
Trial end date:
2022-10-13
Target enrollment:
Participant gender:
Summary
The purpose of this clinical trial is to compare the amount of tafamidis in blood after
taking two different tablet forms of tafamidis
This study is seeking healthy participants over the age of 18.
All participants in the study will receive one tablet of study medicine on the first day,
then receive one dose of the other tablet form 16 days later.
We will compare the amounts in blood for 8 days after taking each dose of the study medicine.
Participants will take part in this study for about 80 days. The first visit is a screening
visit to ensure that participants are appropriate for the study. Up to 28 days later, they
will visit the study clinic twice (and stay overnight in the clinical research center for 8
nights each time). The study team will also call participants over the phone 28 to 35 days
after the last dose of medicine.